Neoadjuvant or adjuvant therapy for resectable esophageal cancer: A clinical practice guideline

BMC Cancer

Volumn 4, Issue , 2004, Pages

  Malthaner, Richard A ^a   Wong, Rebecca K S ^b   Rumble, R Bryan ^c   Zuraw, Lisa ^c   Agboola, O ^d   Citron, M ^d   DeNardi, F G ^d   Fine, S ^d   Fisher, B ^d   Germond, C ^d   Jonker, D ^d   Khoo, K ^d   Kocha, W ^d   Lethbridge, M ^d   Lofters, W ^d   Tandan, V ^d  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d Gastrointest Cancer Dis Site Grp   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; AGE; CANADA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL PRACTICE; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS CANCER; EVIDENCE BASED MEDICINE; HEALTH SURVEY; HUMAN; META ANALYSIS; POSTAL MAIL; PRACTICE GUIDELINE; REVIEW; STANDARD; SYSTEMATIC REVIEW; TREATMENT PLANNING; ADENOCARCINOMA; ADJUVANT THERAPY; ADULT; ESOPHAGUS TUMOR; SQUAMOUS CELL CARCINOMA; STATISTICS;

ADENOCARCINOMA; ADULT; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; HUMANS; ONTARIO; POPULATION SURVEILLANCE; RADIOTHERAPY, ADJUVANT;

EID: 13144274593     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-4-67     Document Type: Review

References (23)

1. Browman GP, Levine MN, Mohide EA, Hayward RS, Pritchard KI, Gafni A, Laupacis A: The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995, 13:502-512.
2. Malthaner RA, Wong RKS, Rumble RB, Zuraw L, members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care: Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Medicine 2004,2:35.
3. Browman GP, Newman TE, Mohide EA, Graham ID, Levine MN, Pritchard KI, Evans WK, Maroun JA, Hodson DI, Carey MS, Cowan DH: Progress of clinical oncology guidelines development using the practice guidelines development cycle: the role of practitioner feedback. J Clin Oncol 1998, 16:1226-1231.
4. Wong RK, Malthaner RA, Zuraw L, Rumble RB, the Cancer Care Ontario Practice Guidelines Initiative Gastrointestinal Cancer Disease Site Group: Combined modality radiotherapy and chemotherapy in the non-surgical management of localized carcinoma of the esophagus: a practice guideline. Int J Radiat Oncol Biol Phys 2003, 55(4): 30-942.
5. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996, 335: 462-467.
6. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001, 19:305-313.
7. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, Lozach P, Ollier JC, Pavy JJ, Mercier M, Sahmoud T: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997, 337:161-167.
8. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, Boutin D, Campion JP, Launois B: A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994, 73: 779-1784.
9. Fok M, McShane J, Law SYK, Wong J: Prospective randomised study in the treatment of oesophageal carcinoma. Asian J Surg 1994, 17: 223-229.
10. Badwe RA, Sharma V, Bhansali MS, Dinshaw KA, Patil PK, Dalvi N, Rayabhattanavar SG, Desai PB: The quality of swallowing for patients with operable esophageal carcinoma. Cancer 1999, 85: 63-768.
11. Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Husted S, Takasugi BJ, Zahurak M: Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol 1990 8:119-127.
12. Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE: Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991, 20:29-36.
13. Forastiere AA: Treatment of locoregional esophageal cancer. Semin Oncol 1992, 19: 57-63.
14. Gill PG, Denham JW, Jamieson GG, Dewitt PG, Yeoh E, Olweny C: Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery. J Clin Oncol 1992, 10:1037-1043.
15. Naunheim KS, Petruska P, Roy TS, Andrus CH, Johnson FE, Schlueter JM, Baue AE: Preoperative chemotherapy and radiotherapy for esophageal carcinoma. J Thorac Cardiovasc Surg 1992, 103: 87-893.
16. Jones DR, Detterbeck FC, Egan TM, Parker LA jr, Bernard SA, Tepper JE: Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg 1997, 64:185-191.
17. Ilson DH, Ajani J, Bhalla K, Forastiere A, Huang Y, Patel P, Martin L, Donegan J, Pazdur R, Reed C, Kelsen DP: Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol 1998, 16: 826-1834.
18. Orringer MB, Marshall B, Iannettoni MD: Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 1999, 230:392-400.
19. Altorki NK: Three-field lymphadenectomy for esophageal cancer. Chest Surg Clin N Am 2000, 10: 553-560.
20. Fiorica F, Cammà C, Venturi A, Giuseppina D, Amadori M, Falchi A: Preoperative radiotherapy and chemotherapy in patients with esophageal carcinoma: a meta-analysis. Int J Radiat Oncol Biol Phys 2002, 54(2):220 (abstract).
21. Urschel JD, Vasan H: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003, 185: 538-543.
22. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, Mantyla M, Modig H, Munck-Wikland E, Rosengren B, Tausjo J, Elgen K: Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992, 16:1104-1109.
23. Apinop C, Puttisak P, Preecha N: A prospective study of combined therapy in esophageal cancer. Hepato gastroenterology 1994, 41:391-393.